Article

March 28, 2011

HIT Press Club AJMC - Dr. Deneen Vojta

Author(s):

Deneen Vojta, MD

Dr. Deneen Vojta, UnitedHealthcare, discusses her paper and answers questions at the Healthcare Innovations and HIT Q&A Session at the National Press Club.

Dr. Deneen Vojta, Senior Vice President of Innovations at UnitedHealthcare, discusses her paper, "Health Information Technology and Health System Redesign: The Quality Chasm Revisited." She also answers questions at the Healthcare Innovations and HIT Q&A Session at the National Press Club in Washington, DC.

Related Videos

Steven Daniel Daveluy, MD, FAAD

Nihar Desai, MD, MPH

Dr Toon Van Gorp

Andrew Kuykendall, MD, Moffitt Cancer Center

Leigh Maria Ramos-Platt, MD

Elizabeth Jones, MD, FAAD

Barry Byrne, MD

Giulio Cossu, MD

Dr Toon Van Gorp

Related Content

CAR T | Image Credit: © Funny-stock.adobe.com

March 21st 2025

Overcoming CAR T Manufacturing Failure in LBCL

Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen receptor (CAR) T-cell administration in patients with relapsed/refractory large B-cell lymphoma (LBCL).

February 25th 2025

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

Pearl Steinzor Arthur L. Jenkins III, MD, FACS

On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.

Person using social media | Image Credit: escapejaja - stock.adobe.com

March 19th 2025

Social Media Insights Shed Light on Patient Experiences With Uncomplicated UTIs

Brooke McCormick

To better understand patient experiences, the researchers analyzed qualitative and quantitative data from their social media posts about uncomplicated urinary tract infections (UTIs).

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

February 11th 2025

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

Maggie L. Shaw George Jones

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, expanding treatment beyond primary care.

Christopher L. Moertel, MD

March 18th 2025

How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas

Hayden E. Klein Christopher L. Moertel, MD

Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.

Clinical research | Image Credit: © peshkova - stock.adobe.com

March 17th 2025

For Neuromuscular Disease Community, an Era of Opportunities and Threats

Christina Mattina

Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.

Related Content

CAR T | Image Credit: © Funny-stock.adobe.com

March 21st 2025

Overcoming CAR T Manufacturing Failure in LBCL

Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen receptor (CAR) T-cell administration in patients with relapsed/refractory large B-cell lymphoma (LBCL).

February 25th 2025

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

Pearl Steinzor Arthur L. Jenkins III, MD, FACS

On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.

Person using social media | Image Credit: escapejaja - stock.adobe.com

March 19th 2025

Social Media Insights Shed Light on Patient Experiences With Uncomplicated UTIs

Brooke McCormick

To better understand patient experiences, the researchers analyzed qualitative and quantitative data from their social media posts about uncomplicated urinary tract infections (UTIs).

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

February 11th 2025

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

Maggie L. Shaw George Jones

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, expanding treatment beyond primary care.

Christopher L. Moertel, MD

March 18th 2025

How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas

Hayden E. Klein Christopher L. Moertel, MD

Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.

Clinical research | Image Credit: © peshkova - stock.adobe.com

March 17th 2025

For Neuromuscular Disease Community, an Era of Opportunities and Threats

Christina Mattina

Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions